# EDGAR Filing Document

**Accession Number:** 0001906425
**File Stem:** 9999999995-26-000394
**Filing Date:** 2026-1
**Character Count:** 1284
**Document Hash:** 94df7b3a30d82eb30a29af51fc6eec58
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**9999999995-26-000394.hdr.sgml**: 20260202

**ACCESSION NUMBER**: 9999999995-26-000394

**CONFORMED SUBMISSION TYPE**: EFFECT

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260130

**DATE AS OF CHANGE**: 20260202

**EFFECTIVENESS DATE**: 20260130

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Invea Therapeutics, Inc
- **CENTRAL INDEX KEY:** 0001906425
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 873198325
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** EFFECT
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-292131
- **FILM NUMBER:** 26585519

**BUSINESS ADDRESS:**
- **STREET 1:** 2614 BOSTON POST ROAD, #33A
- **CITY:** GUILFORD
- **STATE:** CT
- **ZIP:** 06437
- **BUSINESS PHONE:** 203-204-6363

**MAIL ADDRESS:**
- **STREET 1:** 2614 BOSTON POST ROAD, #33A
- **CITY:** GUILFORD
- **STATE:** CT
- **ZIP:** 06437

### UNITED STATES
### SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## Notice of Effectiveness

**Date:** January 30, 2026

**Time:** 14:00:00

**Form Type:** S-1

---

**CIK:** 0001906425

**Company Name:** Invea Therapeutics, Inc

**File Number:** 333-292131